Cero Therapeutics Holdings, Inc. filed a Form S-1 registration statement for an initial public offering on 2024-10-21. It has amended it 4 times. As of its latest filing, on 2025-12-05, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our Common Stock is listed on Nasdaq Capital Market under the symbol “CERO.” On July 18, 2025, the last quoted sale price for the shares of our Common Stock as reported on the Nasdaq Capital Market was $8.73 per share.From the S-1 filed 2025-07-21
Shares offered
We are offering up to 4,000,000 shares of our common stock, par value $0.0001 per share (“Common Stock”), together with 4,000,000 new common warrants (the “Offered Common Warrants”) to purchase up to an aggregate of 4,000,000 shares of our Common Stock and an aggregate of 4,000,000 shares of our Common Stock issuable upon exercise of the Offered Common Warrants.From the S-1/A filed 2025-02-05
Use of proceeds
While we expect to use the net proceeds from this offering as set forth in “ Use of Proceeds ,” we are not obligated to do so.From the S-1 filed 2025-12-05
Net loss or income
We incurred net losses of approximately $8.3 million and $7.3 million for the years ended December 31, 2024 and 2023, respectively, and for the nine months ended September 30, 2025, we incurred a net loss of $15.4 million.From the S-1 filed 2025-12-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-10-21 | Registration statement filed | S-1 |
| 2024-10-22 | Registration statement amended | S-1/A |
| 2024-11-25 | Registration statement amended | S-1/A |
| 2024-11-27 | Registration statement filed | S-1 |
| 2024-12-23 | Registration statement filed | S-1 |
| 2025-01-21 | Registration statement amended | S-1/A |
| 2025-02-05 | Registration statement amended | S-1/A |
| 2025-07-21 | Registration statement filed | S-1 |
| 2025-12-05 | Registration statement filed | S-1 |
Tools for this story
Each opens in a new tab, filled in for Cero Therapeutics Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.